Evidence map›Paper›PMID 34668652›Full record

ArticleCancer medicine2021

Copy number variation analysis of m

Xiaoshuai Wang, Jingwei Yu, Jinbao Chen, Yingdong Hou, Zefeng Du, Haoyang Huang, Siqi Tang, Yueyin Han, Changhai Ding, Zhicheng Xue

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Unraveling the dual role of METTL3-mediated mCancer biology & therapy · 2025
    Review
  3. Review
  4. RNA NNature reviews. Urology · 2024
    Review
  5. Article
  6. Gene polymorphisms ofJournal of Cancer · 2024
    Article
  7. Review
  8. Emerging Regulatory Mechanisms of NPhenomics (Cham, Switzerland) · 2023
    Review
  9. RNA mMolecular oncology · 2023
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Xiaoshuai WangClinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Jingwei YuDepartment of Urology, Kidney and Urology Center, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Jinbao ChenZhongshan Medical College of Sun Yat-sen University, Guangzhou, China.ORCID 0000-0003-0780-0644
Yingdong HouZhongshan Medical College of Sun Yat-sen University, Guangzhou, China.
Zefeng DuZhongshan Medical College of Sun Yat-sen University, Guangzhou, China.
Haoyang HuangZhongshan Medical College of Sun Yat-sen University, Guangzhou, China.
Siqi TangDepartment of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Yueyin HanZhongshan Medical College of Sun Yat-sen University, Guangzhou, China.
Changhai DingClinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Zhicheng XueDepartment of Gastric Surgery, Sun Yat-sen University Cancer Center, China, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Sun Yat-sen University · CNZhujiang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGrowing evidence has demonstrated an indispensable role for N

methodsWe investigated the CNVs on all known m

resultsCNV events of m

conclusionsThere are significant correlations between m

Indexed as

DNA Copy Number VariationsAdenosineBiomarkers, TumorFemaleHumansMaleMethyltransferasesMiddle AgedMutationPrognosisProportional Hazards ModelsUrinary Bladder NeoplasmsAdenosineBiomarkers, TumorMethyltransferasesMETTL3 protein, humanN-methyladenosinebladder cancercopy number variationimmune cellsN6-methyladenosineprognosis

Identifiers

PMID34668652
PMCPMC8559456
OpenAlexW3206811861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.